ArticleOncotarget2019

The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromes.

Yuichi Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.